Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Guangxi Wuzhou Zhongheng Group Co's OCF Margin % or its related term are showing as below:
SHSE:600252'
s OCF Margin % Range Over the Past 10 Years
Min: -6.27 Med: 17.51 Max: 89.55
Current: 4.29
During the past 13 years, the highest OCF Margin % of Guangxi Wuzhou Zhongheng Group Co was 89.55%. The lowest was -6.27%. And the median was 17.51%.
SHSE:600252's OCF Margin % is ranked worse than 63.28% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.025
vs SHSE:600252: 4.29
Guangxi Wuzhou Zhongheng Group Co OCF Margin % Related Terms
Guangxi Wuzhou Zhongheng Group Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Guangxi Wuzhou Zhongheng Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangxi Wuzhou Zhongheng Group Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guangxi Wuzhou Zhongheng Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Guangxi Wuzhou Zhongheng Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) has a OCF Margin % of 2.21% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. This is 87% below median its historical median of 17.51. According to the industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #610 out of 964 companies in the Drug Manufacturers industry, placing it in the top 63.3%.
Is Guangxi Wuzhou Zhongheng Group Co's OCF Margin % too high?
Guangxi Wuzhou Zhongheng Group Co's current OCF Margin % of 2.21% is 87% below median its 10-year median of 17.51. The Drug Manufacturers industry median OCF Margin % is 10.03. Guangxi Wuzhou Zhongheng Group Co's value of 2.21% is 78% below this industry median. Based on the distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #610 out of 964 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Guangxi Wuzhou Zhongheng Group Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi Wuzhou Zhongheng Group Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #610 out of 964 companies for OCF Margin %. This places Guangxi Wuzhou Zhongheng Group Co in the lower half of its industry. The industry median OCF Margin % is 10.03. Guangxi Wuzhou Zhongheng Group Co's value of 2.21% is 78% below this benchmark. While the company's 10-year median is 17.51 vs. the industry median of 10.03, Guangxi Wuzhou Zhongheng Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.03, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangxi Wuzhou Zhongheng Group Co's current OCF Margin % of 2.21% is 78% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangxi Wuzhou Zhongheng Group Co's current OCF Margin % is 2.21%, which is 87% below median its own 10-year median of 17.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi Wuzhou Zhongheng Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.57, compared to a current price of ¥2.15 — trading 36.9% above its estimated fair value. The current OCF Margin % is 2.21%, which is 87% below median its 10-year median of 17.51 and 78% below the Drug Manufacturers industry median of 10.03. Guangxi Wuzhou Zhongheng Group Co's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Guangxi Wuzhou Zhongheng Group Co (SHSE:600252), the current OCF Margin % is 2.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Overvalued in 2026?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co stock appears to be overvalued.
The current stock price of ¥2.15 is trading 36.9% above its estimated GF Value™ of ¥1.57.
GuruFocus considers Guangxi Wuzhou Zhongheng Group Co to be Significantly Overvalued.
Key valuation signals for SHSE:600252:
OCF Margin %: 2.21% (87% below median its 10-year median of 17.51)
GF Value™: ¥1.57 vs. price of ¥2.15 (36.9% above fair value)
Industry Position: 78% below the Drug Manufacturers median (#610 of 964)
No single metric tells the full story. See the SHSE:600252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangxi Wuzhou Zhongheng Group Co Business Description
Guangxi Wuzhou Zhongheng Group Co Ltd is a Chinese company engaged in the production of Chinese medicines. The company is also involved in real estate and health foods.
39GF Score
Get the complete analysis for SHSE:600252
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600252 has been successfully added to your 
